Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
Selma Turkovic, PBM Practitioner at NHS Blood and Transplant, shared a post on LinkedIn:
“Blood Transfusion Education and Discussion Group (BTEDG) webinar 61
Topic: We matched it. We cross‑matched it. They still haemolysed. Unpacking DHTR in Sickle Cell patients.
Can you tell the difference between Delayed Haemolytic Transfusion Reaction (DHTR) and Hyperhaemolysis Syndrome?
Did you know that 56% of DHTRs are missed?
Do you know which laboratory tests are key to confirming and monitoring a DHTR?
Join us to explore these important questions and learn how to recognise and manage this serious transfusion complication.
Wednesday 29th April 2026
14:00–15:00 (UK time)
Microsoft Teams Webinar
Speaker: Daniel Monteiro
Principal Biomedical Scientist, Specialist Red Cell Centre (Synnovis Hub)
Scientific Advisor, NHS Sickle and Thalassaemia Screening Programme
An essential session for anyone involved in transfusion, haemoglobinopathy care, and laboratory haematology.
Please share within your teams and networks.”
More posts featuring Selma Turkovic on Hemostasis Today.
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America
-
Apr 22, 2026, 07:02Michael Wong: Predicting Blood Clots is a Patient Safety Issue